Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BN.1.1.1NUS-CDC-N-1TCTGGTTACTGCCAGTTGAATCTG2445.832835828335R-20385.1US
JN.1.42.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-20387.2Germany
KP.4.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-20389.3US
BN.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20394.2Germany
AY.4.16 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20394.2Germany
AY.4.16 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20407.1China
BN.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-20407.1China
XBB.1.5.39SWon-SCTACATGCACCAGCAACTGT20502311423133F-20413.7South Korea
MK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
JC.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
HN.8EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
BA.5.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
BA.2.77EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
B.1.525 (Eta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
B.1.1.101EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
A.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
B.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-20425.8Germany
B.1.528NUS-CDC-N-3TGTAGCACGATTGCAGCATTG2147.622875228732R-20434.3US
BA.2.10ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20435.8Japan
BQ.1.1.27ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20435.8Japan
XBB.1.5.53ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20435.8Japan
CL.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20435.8Japan
HK.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-20449.7China
BA.5.2.25NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-20458.7South Korea
CH.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20469.9US
B.1.489SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
B.1.44SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
B.1.607SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
P.1 (Gamma)SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
BA.2.13SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
B.1.639SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
B.1.372SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
B.1.177.62SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-20475.1Japan
BA.2.75.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBHNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BL.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.78NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.9.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.64NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBC.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.221.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
DP.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BL.1.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BN.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.177.62NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.82NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.20NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.3.22NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.38.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.79.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used